Nanostructures for Oral Medicine 2017
DOI: 10.1016/b978-0-323-47720-8.00023-7
|View full text |Cite
|
Sign up to set email alerts
|

Design and development of pharmaceutical microprocesses in the production of nanomedicine

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 7 publications
(1 citation statement)
references
References 127 publications
0
1
0
Order By: Relevance
“…Microparticle diameters vary in the micrometer range (typically from 1 µm to 1000 µm). Nanoparticles are considered as the end product of a wide range of chemical, physical, or magnetic interactions and biological processes leading to very small particles within the range of 1–100 nm, according to new definitions by the U.S. Food and Drug Administration [ 109 , 110 , 111 ]. The particle size and surface characteristics can be easily changed to suit the requirements for the delivery of the drugs [ 110 ].…”
Section: Micro- and Nanoparticlesmentioning
confidence: 99%
“…Microparticle diameters vary in the micrometer range (typically from 1 µm to 1000 µm). Nanoparticles are considered as the end product of a wide range of chemical, physical, or magnetic interactions and biological processes leading to very small particles within the range of 1–100 nm, according to new definitions by the U.S. Food and Drug Administration [ 109 , 110 , 111 ]. The particle size and surface characteristics can be easily changed to suit the requirements for the delivery of the drugs [ 110 ].…”
Section: Micro- and Nanoparticlesmentioning
confidence: 99%